Blue Sky, REITS, small cap investing, biotech and more

In this week's #AskAlan Facebook livestream, we discuss Blue Sky, REITS, small cap investing, biotech and more.

Questions answered: 

• Have you any lowdown on AU8, really struggling now, and showing signs of tanking?

• What do you make of the STO takeover bid Alan? It seemed to have turned the corner but now we have this 'low blow' offer which the board appear to be entertaining.

• Any thoughts on the Evans Dixons IPO?

• Would you explain the difference between the pre and after tax NTA quoted by managed funds and REITS - for some the NTA is lower after tax, for others it is higher. Fees are calculated pre tax NTA I believe.

• Looking at small cap investment opportunities for our SMSF. Interested in your thought on small cap managed funds v specialised small cap listed investment firms. 

• During the week I came across the following chart that tells a BIG story. Knowing your positive disposition towards their ability to speak volumes, I was wondering if you're hearing the same disturbing drumbeat, or portentous tea leaves for where we're heading on the global trade front. Basically it's a case of follow what China does, not says about. 10 year sovereign spread is blowing out as USD weakens against everything. https://pbs.twimg.com/media/DZMQ1gBU8AQgkGi.jpg:large

• Some of us are likely losers of dividend imputation if Labor comes to power, and are looking for un-franked, and/or fixed income, investment options. Would you give a general opinion of the Gryphon Capital Income Trust IPO.

• I’d like to understand why Amcor price has dropped so significantly - weren’t they going to be the next blue chip no long ago?

• Regarding Biotech investments, is the general goal to await a takeover by a big Pharma company, or do the ‘little guys’ sometimes breakthrough on their own. Considering Imugene (IMU) who have a unique potential for cancer treatments, with a potential global sales per year of about $8 billion USD.